Aquestive Therapeutics Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
AQST Nasdaq 2834 https://aquestive.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Aquestive Therapeutics Inc

Aquestive Therapeutics to Report Third Quarter 2021 Financial Results and Recent Business Highlights on November 2 and Host Conference Call on November 3 at 8:00 a.m. ET - Oct 14th, 2021 12:00 pm
Aquestive Therapeutics Reaches Agreement to Extend Principal Payments Due Under Credit Facility to March 30, 2023 and Receives Bridge Waiver of Principal Debt Payment in Advance of Concluding Formal Agreement - Oct 6th, 2021 9:59 pm
IntelGenx and Aquestive Therapeutics Partner with Leading Men’s Health Company to Market Tadalafil Oral Films in the U.S. - Sep 29th, 2021 8:30 pm
Aquestive Therapeutics to Participate in Three Investor Conferences in September - Sep 7th, 2021 12:00 pm
What Kind Of Shareholders Hold The Majority In Aquestive Therapeutics, Inc.'s (NASDAQ:AQST) Shares? - Sep 3rd, 2021 11:25 am
Aquestive Therapeutics Negotiates Six Month Extension to June 30, 2022 for Additional Libervant™ Related Capital Under Current Debt Agreement - Aug 9th, 2021 12:00 pm
Aquestive Therapeutics to Participate in 12th Annual Wedbush PacGrow Healthcare Virtual Conference - Aug 6th, 2021 12:00 pm
Aquestive Therapeutics (AQST) Reports Q2 Loss, Tops Revenue Estimates - Aug 3rd, 2021 11:25 pm
Aquestive Therapeutics Reports Second Quarter 2021 Financial Results, Provides Business Update and Raises Full Year Revenue Guidance - Aug 3rd, 2021 9:55 pm
Earnings Preview: Aquestive Therapeutics (AQST) Q2 Earnings Expected to Decline - Jul 27th, 2021 7:02 pm
Aquestive Therapeutics to Report Second Quarter 2021 Financial Results and Recent Business Highlights on August 3 and Host Conference Call on August 4 at 8:00 a.m. ET - Jul 21st, 2021 12:00 pm
Aquestive Therapeutics Announces FDA Acceptance of New Drug Application (NDA) Resubmission for Libervant™ (diazepam) Buccal Film - Jul 19th, 2021 1:29 pm
How Much Did Aquestive Therapeutics'(NASDAQ:AQST) Shareholders Earn From Share Price Movements Over The Last Year? - Jul 5th, 2021 5:55 am
Aquestive Therapeutics Resubmits New Drug Application for Libervant™ (diazepam) Buccal Film - Jun 24th, 2021 12:00 pm
SCYNEXIS to Present Commercial Launch Update for BREXAFEMME® (ibrexafungerp tablets) - Jun 23rd, 2021 12:30 pm
Is Aquestive Therapeutics, Inc. (AQST) A Good Stock To Buy? - Jun 21st, 2021 10:50 pm
Aquestive Therapeutics Announces Leadership Transition of Chief Financial Officer - Jun 21st, 2021 1:15 pm
Aquestive Therapeutics to Participate in JMP Securities and BMO Capital Market Investor Conferences - Jun 9th, 2021 12:30 pm
Aquestive Therapeutics to Participate in 2021 RBC Capital Markets Global Healthcare Conference - May 11th, 2021 1:27 pm
Aquestive Therapeutics, Inc. to Host Earnings Call - May 5th, 2021 10:15 am